FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
Merilog is the third insulin biosimilar product approved by the FDA and joins the two long-acting insulin biosimilar products ...
The Financial Express18h
FDA gives nod to first rapid-acting insulin biosimilar for diabetes treatment
The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin aspart) for the ...
FDA approves Sanofi biosimilar product for treatment of diabetes
The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...
Medscape29d
Proinsulin-Transferrin Fusion Protein as a Novel Long-Acting Insulin Analog for the Inhibition of Hepatic Glucose Production
As expected, INS (4.5 nmol/kg) exhibited a sharp and fast BG decrease from 400 to 140 mg/dL (65% decrease) at 1 h, and the BG subsequently recovered to the levels similar to the vehicle group at 4 ...
verywellhealth11d
A Complete Guide to Type 1 Diabetes Medications
The pump gives you a basal dose of short- or rapid-acting insulin every hour. You can also calculate the mealtime/correction insulin dose to receive from your pump when you eat or when your blood ...
Frontiers13d
Access to Insulin Products in Pakistan: A National Scale Cross-Sectional Survey on Prices, Availability, and Affordability
and mixed human insulin were 1.03, 1.02, and 1.09, respectively. The NDWs for OBs of rapid-acting analog, long-acting analog, and mixed analog insulin were 4.78, 5.25, and 4.83, respectively. The NDWs ...
MedPage Today1d
FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
FDA approves first rapid-acting insulin
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
Sanofi gets FDA approval for NovoLog insulin biosimilar
Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...
Medscape15d
Inhaled Insulin for Diabetes Mellitus
Exubera, a rapid-acting insulin in powder form, has been studied extensively in patients with type 1 and type 2 diabetes mellitus. The AERx Insulin Diabetes Management System delivers a liquid ...